Influenza virus-like particles containing M2 induce broadly cross protective immunity.
Current influenza vaccines based on the hemagglutinin protein are strain specific and do not provide good protection against drifted viruses or emergence of new pandemic strains. An influenza vaccine that can confer cross-protection against antigenically different influenza A strains is highly desir...
Main Authors: | Jae-Min Song, Bao-Zhong Wang, Kyoung-Mi Park, Nico Van Rooijen, Fu-Shi Quan, Min-Chul Kim, Hyun-Tak Jin, Andrew Pekosz, Richard W Compans, Sang-Moo Kang |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3022578?pdf=render |
Similar Items
-
Virus-like particle vaccine protects against 2009 H1N1 pandemic influenza virus in mice.
by: Fu-Shi Quan, et al.
Published: (2010-02-01) -
Changes in human Langerhans cells following intradermal injection of influenza virus-like particle vaccines.
by: Marc Pearton, et al.
Published: (2010-08-01) -
Correction: Changes in Human Langerhans Cells Following Intradermal Injection of Influenza Virus-Like Particle Vaccines
by: Marc Pearton, et al.
Published: (2010-01-01) -
Correction: Changes in Human Langerhans Cells Following Intradermal Injection of Influenza Virus-Like Particle Vaccines.
by: Marc Pearton, et al.
Published: (2010-01-01) -
Protective effect of ginseng polysaccharides on influenza viral infection.
by: Dae-Goon Yoo, et al.
Published: (2012-01-01)